Yingdong Zhao

Author PubWeight™ 56.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 2007 6.09
2 MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010 2.48
3 Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res 2002 2.21
4 A signature of immune function genes associated with recurrence-free survival in breast cancer patients. Breast Cancer Res Treat 2011 1.99
5 A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". J Transl Med 2008 1.77
6 Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc Natl Acad Sci U S A 2002 1.72
7 Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008 1.57
8 Common cancer biomarkers. Cancer Res 2006 1.56
9 Selection and validation of endogenous reference genes using a high throughput approach. BMC Genomics 2004 1.45
10 Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection. Genome Biol 2007 1.38
11 How large a training set is needed to develop a classifier for microarray data? Clin Cancer Res 2008 1.38
12 The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses. Clin Cancer Res 2002 1.35
13 Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med 2009 1.31
14 Gene Set Expression Comparison kit for BRB-ArrayTools. Bioinformatics 2007 1.28
15 Non-negative matrix factorization of gene expression profiles: a plug-in for BRB-ArrayTools. Bioinformatics 2009 1.26
16 Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis. Cancer Res 2008 1.22
17 Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment. BMC Med Genomics 2011 1.17
18 Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma. Clin Cancer Res 2011 1.10
19 Innate gene repression associated with Mycobacterium bovis infection in cattle: toward a gene signature of disease. BMC Genomics 2007 1.07
20 Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence. Stem Cell Res 2013 1.05
21 Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines. Clin Cancer Res 2011 1.04
22 Strengths and limitations of laboratory procedures for microRNA detection. Cancer Epidemiol Biomarkers Prev 2010 1.03
23 Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. J Transl Med 2013 1.03
24 Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol 2003 1.00
25 A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides applicable in the clinical settings. J Transl Med 2003 0.99
26 The stable traits of melanoma genetics: an alternate approach to target discovery. BMC Genomics 2012 0.95
27 A comparison of phase II study strategies. Clin Cancer Res 2009 0.93
28 HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood 2005 0.93
29 Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog 2005 0.92
30 IRF5 gene polymorphisms in melanoma. J Transl Med 2012 0.86
31 High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis. J Neuroimmunol 2005 0.86
32 Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL. J Immunol 2002 0.85
33 Quality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling. Mol Ther 2012 0.85
34 Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery. AIDS 2010 0.85
35 Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J Immunol 2006 0.85
36 Antigen stimulation of peripheral blood mononuclear cells from Mycobacterium bovis infected cattle yields evidence for a novel gene expression program. BMC Genomics 2008 0.84
37 Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol Biomarkers Prev 2012 0.84
38 Toward synthetic combinatorial peptide libraries in positional scanning format (PS-SCL)-based identification of CD8+ Tumor-reactive T-Cell Ligands: a comparative analysis of PS-SCL recognition by a single tumor-reactive CD8+ cytolytic T-lymphocyte clone. Cancer Res 2002 0.83
39 A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon. PLoS One 2012 0.82
40 Findings on T cell specificity revealed by synthetic combinatorial libraries. J Immunol Methods 2002 0.80
41 Partial immunity and vaccination for influenza. J Comput Biol 2010 0.80
42 T-cell epitope prediction with combinatorial peptide libraries. J Comput Biol 2002 0.79
43 OpenGeneMed: a portable, flexible and customizable informatics hub for the coordination of next-generation sequencing studies in support of precision medicine trials. Brief Bioinform 2017 0.79
44 Combining positional scanning peptide libraries, HLA-DR transfectants and bioinformatics to dissect the epitope spectrum of HLA class II cross-restricted CD4+ T cell clones. J Immunol Methods 2009 0.79
45 Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates. Hum Gene Ther Methods 2012 0.77
46 Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus. J Transl Med 2015 0.76
47 "Sequencing-grade" screening for BRCA1 variants by oligo-arrays. J Transl Med 2008 0.75